BRASILIA (Reuters) - Russian vaccine developers cheered hard-won access to Brazil’s market last week, but with less than a million doses cleared for import, public health experts say the approval is more like a late-stage trial for the Sputnik V shot. Read full story
from mdnursyazwi https://ift.tt/2REdbLT
via http://www.rssmix.com/
from Tumblr https://dearluce.tumblr.com/post/653537681945542657
No comments:
Post a Comment